BioSimulytics

Leading Innovators in Molecular Modelling Technology - Europe
GHP Pioneer Award in AI-Powered Drug Development
Winners image
<p>BioSimulytics is a university spin-out company founded in 2019 specialising in the use of AI Machine Learning technology for in-silico drug development. The company&#8217;s proprietary patented technology enables fast and accurate predictive modelling of the force-field configuration and optimal crystal structure of new molecular entities to support Pharma R&#038;D in developing effective new drugs with higher success rate.</p>